SHANGHAI, July 11,
2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD)
("Zhongchao" or the "Company"), a platform-based internet
technology company offering services for patients with cancer and
other major diseases, today announced that it cooperates with
Shanghai Ximalaya Technology Co., Ltd. ("Ximalaya"), a widely
popular Chinese online audio sharing platform in China, to launch the first series of audio
courses dedicated to cancer education.
The cancer education course series, aptly named "Let's Talk
About Tumors", is presented by a team of esteemed medical
professionals from Grade A Tertiary Hospitals. Interspersed with
engaging anecdotes, the series is designed to enhance patients' and
public's understanding of various aspects of cancer, including its
treatment, daily care requirements, and medication guidance, and
thereby aims to improve the perception of the disease and increase
public health literacy.
The audio format of the series has been thoughtfully designed to
cater to older cancer patients who often face challenges in reading
or watching visual contents due to age-related eye conditions and
disease-related complications. The first season of "Let's Talk
About Tumors" is comprised of 14 episodes that is open to the
public to subscribe for free. These episodes address topics of
patients' common concerns, including "Immunotherapy," "Living with
Cancer," "Nutritional Treatment," "Precancerous Lesions" and
others, intending to elevate the overall health literacy in the
cancer community.
As per the Globocan 2020 report, China sees approximately 4,568,754 new cancer
cases in 2020, with a total of 9,294,006 prevalent cases for the
last five years as of 2020. The "Healthy China Initiative
(2019-2030)" published by Healthy China Initiative Promotion
Committee aims at improving the awareness rate of core cancer
prevention and treatment knowledge to reach to no less than 70% and
80% by 2022 and 2030, respectively. Zhongchao expects that the
"Let's Talk About Tumors" course series, available on the Ximalaya
platform, could contribute towards achieving this national goal and
promoting tumor-related knowledge throughout society. Established
in 2012, Ximalaya is dedicated to empowering people to share wisdom
and embrace a better life via voice. As of the first three quarters
of 2022, Ximalaya's average monthly active users across all
scenarios reached 282 million (source: Kuaikeji,
https://news.mydrivers.com/1/886/886105.htm).
Weiguang Yang, Chairman and Chief
Executive Officer of Zhongchao, commented, "Our partnership with
Ximalaya underscores our dedication to enhancing health literacy
and delivering value-added services to our users. Through this
audio course series, we aim not just to educate patients but also
equip them with essential knowledge required for effective disease
management."
About Zhongchao Inc.
Zhongchao Inc. is an offshore holding company incorporated in
the Cayman Islands. It
consolidates the financial results of a variable interest entity,
Zhongchao Medical Technology (Shanghai) Limited, and its subsidiaries (the
"PRC operating entities") through a series of contractual
arrangements. Zhongchao Inc. is a platform-based internet
technology company offering services to patients with oncology and
other major diseases. The PRC operating entities provide online
healthcare information, professional training and educational
services to healthcare professionals under their "MDMOOC" platform
(www.mdmooc.org), offer patient management services in the
professional field of tumor and rare diseases through Zhongxin,
offer internet healthcare services through Zhixun Internet
Hospital, and pharmaceutical services through Xinjiang Medical and
operate an online information platform, Sunshine Health Forums, to
general public. More information about the Company can be found at
its investor relations website at http://izcmd.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies; the Company's future
business development; product and service demand and acceptance;
changes in technology; economic conditions; the growth of the
professional training and educational services market in
China and the other international
markets the Company plans to serve; reputation and brand; the
impact of competition and pricing; government regulations;
fluctuations in general economic and business conditions in
China and the international
markets the Company plans to serve and assumptions underlying or
related to any of the foregoing and other risks contained in
reports filed by the Company with the SEC, the length and severity
of the recent coronavirus outbreak, including its impacts across
our business and operations. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward–looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please contact:
At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 13901629242
Investor Relations: Sherry Zheng
Weitian Group LLC
Email: shunyu.zheng@weitian-ir.com
Phone: +1 718-213-7386
View original
content:https://www.prnewswire.com/news-releases/zhongchao-inc-partners-with-ximalaya-to-launch-the-first-audio-course-series-for-cancer-education-301872514.html
SOURCE Zhongchao Inc.